In addition, the concentration of RBP4 in the blood is associated with cardiovascular risk factors associated with insulin resistance and CHD, circulating RBP4 can be a marker of metabolic complications and atherosclerosis and used to assess CHD [26,27]. Here, RBP4 is linked to Insulin resistance.